Fund Holdings — Sands Capital Alternatives, LLC

Total Portfolio Value:
$507.82M
Total Bought:
$107.01M
Total Sold:
$4.13M
Net Transaction:
+$102.88M
Notable People:
Sands Capital Management, Lp, Erin Elizabeth Soule
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Klaviyo, Inc.COM SER A(KVYO)3,443,5153,515,065+71,550$104.20M$118.04M23.24%+$13.84M
Nu Holdings Ltd.CL A(NU)7,164,3557,175,434+11,079$73.36M$98.45M19.39%+$25.08M
DoorDash, Inc.CL A(DASH)380,704381,202+498$69.58M$93.97M18.50%+$24.39M
Beta Bionics, Inc.(BBNX)3,103,7823,570,113+466,331$37.99M$51.98M10.24%+$13.99M
Coupang, Inc.CL A(CPNG)843,476849,031+5,555$18.50M$25.44M5.01%+$6.94M
Inhibikase Therapeutics, Inc.(IKT)10,950,00010,950,0000$23.98M$21.35M4.20%-$2.63M
Monday Com LtdSHS
SHS
49,90858,336+8,428$12.14M$18.35M3.61%+$6.21M
Samsara Inc.CL A(IOT)253,432438,485+185,053$9.71M$17.44M3.43%+$7.73M
Datadog, Inc.CL A(DDOG)117,930118,707+777$11.70M$15.95M3.14%+$4.25M
CrowdStrike Holdings, Inc.CL A(CRWD)15,56015,615+55$5.49M$7.95M1.57%+$2.47M
Toast, Inc.CL A(TOST)210,611156,604-54,007$6.99M$6.94M1.37%-$50.0K
Tarsus Pharmaceuticals, Inc.(TARS)170,000170,0000$8.73M$6.89M1.36%-$1.85M
Snowflake Inc.CL A(SNOW)26,82827,005+177$3.92M$6.04M1.19%+$2.12M
10x Genomics, Inc.CL A(TXG)481,770481,7700$4.21M$5.58M1.10%+$1.37M
Acumen Pharmaceuticals, Inc.(ABOS)3,417,0753,417,0750$3.76M$3.96M0.78%+$205.0K
BioAge Labs, Inc.(BIOA)786,353786,3530$2.96M$3.25M0.64%+$291.0K
Acrivon Therapeutics Inc2,122,6052,122,6050$4.31M$2.53M0.50%-$1.78M
Candel Therapeutics, Inc.(CADL)405,837405,8370$2.29M$2.05M0.40%-$239.4K
Taysha Gene Therapies, Inc.(TSHA)724,873724,8730$1.01M$1.67M0.33%+$666.9K
UiPath, Inc.CL A(PATH)395,8550-395,855$4.08M$0—-$4.08M
Page 1 of 1
Sands Capital Alternatives, LLC — 13F Holdings — Q2 2025 | TickerTrail